- Fluticasone Propionate (Aqueous) 0.05% w/v Nasal Spray
- Mometasone Fuorate 0.20 %w/v Nasal Spray
- Moxifloxacin 400 mg Tablet
- Azithromycin 250 mg, 500 mg Tablet/Suspension
- Fluticasone Propionate + Salmetrol Dry Powder 50 mcg + 100/250/500 mcg
Esteemed in 2003, we are committed to make life "SAVA" with our range of healthcare products and services that are benchmark of 'Superlative Quality, Enviable Economy'. Built on the sturdy pillars of financial solidarity, stability, reliability, operational expertise, infrastructure, technology and revolutionary business strategy and execution. The Group is amongst one of the fastest emerging pharmaceutical organizations of repute from India.
VISION AND MISSION
At SAVA we perceive the perfect vision (20:20) to be attained by the year 2020 by whence SAVA aims to be 'the choice' as in